Events
TDP43 Summit
Join us for the 2025 Summit Advancing TDP43 Biomarkers: From Discovery to Application, hosted by the University of Wisconsin-Madison and presented by Alamar Biosciences, Enigma Biomedical Group, and our very own CLARiTI. We invite scientists interested in TDP-43 biomarker research to join us for this dynamic summit - a collaborative forum to share discoveries and lessons learned and to identify gaps and opportunities in this challenging field. We hope the summit fosters collaboration as we together shape the future of neurodegenerative disease research. Please RSVP to register for the event and to take advantage of this unique opportunity to engage with leaders in the field. Virtual registration will close on June10, 2025. As a virtual attendee, you'll have access to live-streamed sessions and opportunities for Q&A with top researchers in the field. The Summit will be hosted by Drs. Henrik Zetterberg, Hartmuth Kolb, and Sterling Johnson. Please feel free to invite colleagues. Visit our website here for more information about the Summit, our speakers, and to view the agenda.
Media Mentions
Brain scans begin for nationwide Alzheimer’s disease study - School of Medicine and Public Health
Research participants have begun volunteering for brain scans at the University of Wisconsin School of Medicine and Public Health in Madison for a national study on Alzheimer’s disease and related dementias.
University of Washington plays key role in $150M CLARiTI study for Alzheimer’s and related dementias research
UW SPH
The University of Washington (UW) has received a portion of a new $150 million grant to collaborate on a study called Clarity in Alzheimer’s Disease and Related Dementias Research Through Imaging (CLARiTI). The five-year study funded by the National Institute on Aging will provide cutting-edge imaging and blood-based biomarker data for researchers worldwide to advance Alzheimer’s and related dementias research.
UW–Madison receives $150 million grant to lead nationwide Alzheimer’s disease study
The University of Wisconsin School of Medicine and Public Health (SMPH) has been awarded funding from the National Institutes of Health (NIH) for a nationwide research initiative to investigate the neurobiology of Alzheimer’s disease and related dementias.